{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"84.00","upperLimit":"521.00","value":"128.00"},{"groupId":"OG001","lowerLimit":"64.00","upperLimit":"509.00","value":"133.00"}]}],"title":"Baseline, n=208, 387"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"30.00","upperLimit":"398.00","value":"112.00"},{"groupId":"OG001","lowerLimit":"31.00","upperLimit":"502.00","value":"115.00"}]}],"title":"Week 1, n=227, 443"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.00","upperLimit":"297.00","value":"79.00"},{"groupId":"OG001","lowerLimit":"36.00","upperLimit":"596.00","value":"111.00"}]}],"title":"Week 2, n=227, 438"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"17.00","upperLimit":"275.00","value":"43.50"},{"groupId":"OG001","lowerLimit":"5.00","upperLimit":"430.00","value":"90.00"}]}],"title":"Week 4, n=218, 430"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"12.00","upperLimit":"261.00","value":"40.00"},{"groupId":"OG001","lowerLimit":"22.00","upperLimit":"315.00","value":"89.00"}]}],"title":"Week 6, n=197, 423"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"15.00","upperLimit":"320.00","value":"41.00"},{"groupId":"OG001","lowerLimit":"22.00","upperLimit":"249.00","value":"86.00"}]}],"title":"Week 8, n=189, 414"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.00","upperLimit":"284.00","value":"44.00"},{"groupId":"OG001","lowerLimit":"25.00","upperLimit":"298.00","value":"91.50"}]}],"title":"Week 12, n=165, 404"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.00","upperLimit":"280.00","value":"43.00"},{"groupId":"OG001","lowerLimit":"26.00","upperLimit":"376.00","value":"93.00"}]}],"title":"Week 16, n=141, 377"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"18.00","upperLimit":"325.00","value":"44.00"},{"groupId":"OG001","lowerLimit":"25.00","upperLimit":"339.00","value":"89.00"}]}],"title":"Week 20, n=135, 363"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"21.00","upperLimit":"333.00","value":"43.00"},{"groupId":"OG001","lowerLimit":"18.00","upperLimit":"276.00","value":"92.00"}]}],"title":"Week 24, n=89, 248"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"22.00","upperLimit":"345.00","value":"45.00"},{"groupId":"OG001","lowerLimit":"17.00","upperLimit":"207.00","value":"89.50"}]}],"title":"Week 28, n=73, 202"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"24.00","upperLimit":"338.00","value":"44.40"},{"groupId":"OG001","lowerLimit":"21.00","upperLimit":"406.00","value":"91.00"}]}],"title":"Week 32, n=69, 183"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.00","upperLimit":"315.00","value":"44.50"},{"groupId":"OG001","lowerLimit":"21.00","upperLimit":"209.00","value":"91.00"}]}],"title":"Week 36, n=68, 173"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"22.00","upperLimit":"276.00","value":"44.00"},{"groupId":"OG001","lowerLimit":"30.00","upperLimit":"226.00","value":"93.00"}]}],"title":"Week 40, n=64, 169"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"22.00","upperLimit":"320.00","value":"48.00"},{"groupId":"OG001","lowerLimit":"27.00","upperLimit":"238.00","value":"93.50"}]}],"title":"Week 44, n=65, 168"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.00","upperLimit":"318.00","value":"40.00"},{"groupId":"OG001","lowerLimit":"5.00","upperLimit":"420.00","value":"90.00"}]}],"title":"End of Treatment/Withdrawal, n=212, 419"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.00","upperLimit":"318.00","value":"40.00"},{"groupId":"OG001","lowerLimit":"5.00","upperLimit":"420.00","value":"90.00"}]}],"title":"Last on Treatment, n=232, 447"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5.00","upperLimit":"358.00","value":"54.00"},{"groupId":"OG001","lowerLimit":"5.00","upperLimit":"304.00","value":"82.00"}]}],"title":"4 Week Follow-Up, n=205, 400"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.00","upperLimit":"311.00","value":"56.00"},{"groupId":"OG001","lowerLimit":"1.00","upperLimit":"350.00","value":"67.00"}]}],"title":"12 Week Follow-Up, n=196, 396"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"9.00","upperLimit":"433.00","value":"56.00"},{"groupId":"OG001","lowerLimit":"7.00","upperLimit":"340.00","value":"60.00"}]}],"title":"24 Week Follow-Up, n=193, 391"}],"denoms":[{"counts":[{"groupId":"OG000","value":"232"},{"groupId":"OG001","value":"447"}],"units":"Participants"}],"description":"Blood taken from peripheral blood vessels was used for the measurement of platelet counts.","dispersionType":"Full Range","groups":[{"description":"Participants completing the OL Phase were administered matching placebo tablets QD in combination with antiviral therapy (peginterferon alfa-2a and ribavirin) for a duration of either 24 or 48 weeks (for participants with Genotype 2/3) or 48 weeks (for participants with Non-Genotype 2/3).","id":"OG000","title":"Placebo+Antiviral Therapy: DB Phase"},{"description":"Participants completing the OL Phase continued on the same dose of eltrombopag received in the OL Phase (dose that effectively raised platelets to \\>=90 Gi/L) in combination with antiviral therapy (peginterferon alfa-2a and ribavirin) for a duration of either 24 or 48 weeks (for participants with Genotype 2/3) or 48 weeks (for participants with Non-Genotype 2/3).","id":"OG001","title":"Eltrombopag+Antiviral Therapy: DB Phase"}],"paramType":"MEDIAN","populationDescription":"ITT Population. Only those participants contributing data at the indicated time points were analyzed. The Last On Treatment assessment refers to the actual last treatment assessment, not necessarily to the End of Treatment assessment entered by the Investigator.","reportingStatus":"POSTED","timeFrame":"DB Phase: Baseline; Weeks 1, 2, 4, 6, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44; End of Treatment (up to Week 48); 4-week Follow-up (FU) (up to Week 52); 12-week FU (up to Week 60); and 24-week FU (up to Week 72)","title":"Median Platelet Count at the Indicated Time Points During the DB Phase","type":"SECONDARY","unitOfMeasure":"Gi/L"}